Clinical Trials Network Award supports institutions, organizations, and physician groups in building networks to extend phase 2 and phase 3 cancer trials to care facilities that lack access.
Funder: Cancer Prevention & Research Institute of Texas
Due Dates: December 8, 2026 (Application deadline)
Funding Amounts: Up to $2.5 million over 5 years
Summary: Supports networks that extend phase 2 and phase 3 cancer clinical trial access to cancer care facilities currently lacking access.
Key Information: Lead applicants must have an established clinical trials infrastructure and portfolio.
The Cancer Prevention & Research Institute of Texas (CPRIT) offers this award through its Academic Research program to develop and oversee networks of cancer care facilities that currently lack access to clinical trials. Institutions, organizations, or physician groups with established trial infrastructure and portfolios lead the networks, extending access to appropriate phase 2 and phase 3 trials.
Network affiliates will use a common institutional review board (IRB) and share a web-based clinical trials management support system. These shared resources support the program’s goal of connecting successful networks into a statewide Texas Cancer Clinical Trial Network.